Gilvetmab (anti-PDCD1) is a potent caninized anti PD-1 monoclonal antibody. Gilvetmab (anti-PDCD1) blocks the interaction between PD-1 and its ligand PDL-1.
规格
产品名称
Gilvetmab (anti-PDCD1)
别名
吉维单抗
英文别名
CD279 antibody|CD279 antigen antibody|hPD 1 antibody|hPD l antibody|hPD-1 antibody|hSLE1 antibody|PD 1 antibody|PD-1 antibody|PD1 antibody|PDCD 1 antibody|PDCD1 antibody|Programmed cell death 1 antibody|Programmed cell death 1 protein antibody|Programmed cell death protein 1 antibody|Protein PD 1 antibody|Protein PD-1 antibody|SLEB2 antibody|Systemic lupus erythematosus susceptibility 2 antibody|CD279 antigen|CD279|hPD-1|PD1|PD-1|PDCD1|programmed cell death 1|programmed cell death protein 1|Protein PD-1|SLEB2|hPD-l|hSLE1
Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂
No
储存条件
-80℃储存,避免反复冻融
运输条件
特低温运输
稳定性与储存
在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
图片
Gilvetmab (anti-PDCD1) (Ab191968) - ELISA Immobilized huPD-1-ECD-GSV0-C-his at 2.0 μg/mL can bind Gilvetmab (anti-PDCD1) (Ab191968) with the EC₅₀ of 16.04 ng/mL.
Gilvetmab (anti-PDCD1) (Ab191968) - SEC The purity of Gilvetmab (anti-PDCD1) (Ab191968) is more than 95% verified by HPLC.
高级数据
关联靶点(人)
PDCD1Tclin程序性细胞死亡蛋白 1(Programmed cell death protein 1)
(0 活性数据)